Live Breaking News & Updates on Joe Schachle

Stay updated with breaking news from Joe schachle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Opus Genetics Hosts Inaugural Patient Advocacy Outreach

Virtual event details Opus’ unique and transparent approach to building company centered on patient need, provides update on lead programs in Leber. ....

University Of Pennsylvania , United States , Jennifer Hunt , Heather Anderson , Ben Yerxa , Joe Schachle , Development Officer , Research Triangle Park , Drug Administration , Rd Fund , Foundation Fighting Blindness , Chief Executive Officer , Ash Jayagopal , Chief Scientific Officer , Chief Operating Officer , Chief Development , Investigational New Drug , Opu Youtube , Opus Genetics ,

Startup spotlight: Opus Genetics, with $19M, works to advance cures for blinding retinal diseases

RALEIGH - Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed ....

United States , University Of Pennsylvania , Junwei Sun , Tjean Bennett , Ben Yerxa , Joe Schachle , Williamf Chatlos , Harvard Medical School , Ocular Genomics Institute , Perelman School Of Medicine , Foundation Fighting Blindness , Penn Center , Manning Family Foundation , Rd Fund , Opus Genetics , Bios Partners , Emeritus Professor , Perelman School , Advanced Retinal Ocular Therapeutics , Eric Pierce , Massachusetts Eye , Harvard Medical , Chief Operating Officer Joe Schachle , Chief Scientific Officer , Ash Jayagopal , Spark Therapeutics ,

Raleigh startup Opus Genetics, with $19M in funding and new execs, to begin 3rd preclinical trial

RALEIGH - Opus Genetics, launched earlier this year with $19 million in invested capital, has signed an agreement to license its third preclinical program from ....

United States , Joe Schachle , Williamf Chatlos , Harvard Medical School , Ocular Genomics Institute , Opus Genetics , Massachusetts Eye , Eric Pierce , Ash Jayagopal ,

BioSpace Mover & Shakers, Oct. 22

BioSpace Mover & Shakers, Oct. 22 - read this article along with other careers information, tips and advice on BioSpace ....

New York , United States , United Kingdom , Charles River , Noord Holland , New Zealand , Dana Farber Cancer Institute , South Korea , August Allen , Teresa Bair , Eli Lilly , Sumitovant Biopharma , Dushyantb Varshney , Nadim Ahmed , Emile Voest , Myrtle Potter , Joe Schachle , C Daniel Myers , Masonw Freeman , Acerta Pharma , Jim Hartman , Graham Dixon , Graham Birrell , Cincor Pharma , Lillianl Siu , Valeriem Jansen ,

Chutes & Ladders—Athira CEO resigns after investigation confirms she altered research

Athira Pharma's CEO resigns after investigation confirms she altered research during graduate school. vTv Therapeutics named healthcare investor Deepa Prasad its new CEO and president. Opus Genetics snagged a new chief scientific officer and chief operating officer. ....

United States , August Allen , Stephen Holcombe , Thomast Thomas , Sumitovant Biopharma , Michael Covington , Myrtle Potter , Joe Schachle , Mark Niemaszek , Athira Pharma , Patrick Staudt , Gisela Paulsen , Jim Hartman , Ted Chan , Haijun Sun , Mark Litton , Avalyn Pharma , Kyle Smith , Gregg Nyberg , Valerie Jansen , Cincor Pharma , Pavan Cheruvu , Deepa Prasad , Hamid Erfanian , Philip Lambert , Mason Freeman ,